Dry Age Macular Degeneration Market Report 2023-2033 | Industry Size, Growth and Latest Insights
The report offers a comprehensive analysis of the dry age macular degeneration market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market's performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the dry age macular degeneration market.
Request for a Sample Copy of this Report:https://www.imarcgroup.com/dry-age-macular-degeneration-market/requestsample
The dry age macular degeneration market is largely driven by the growing aging population, who are more prone to macular cell deterioration leading to retinal scarring. An upswing in the prevalence of risk factors including smoking, obesity, high blood pressure, and poor diet also stokes market growth. The escalating demand for antioxidant vitamins and minerals, such as vitamins C, E, beta-carotene, zinc, and copper, which mitigate cellular damage by neutralizing free radicals in the retina, augments market positivity.
Additionally, the increasing utilization of anti-angiogenic
drugs, like ranibizumab and aflibercept, injected directly into the eye to slow
abnormal blood vessel growth, propels the market. Laser photocoagulation
therapy's rising adoption, offering benefits such as drusen resolution, vision
loss prevention, and quality of life enhancement, is anticipated to drive the
dry age macular degeneration market in the forecast period.
Key Segmentation:
Countries Covered:
- United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country:
- Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the dry age macular degeneration market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the dry age macular degeneration market
• Reimbursement scenario in the market
• In-market and pipeline drugs
This report also provides a detailed analysis of the current dry age macular degeneration marketed drugs and late-stage pipeline drugs.
In-Market Drugs:
- Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
- Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance
Competitive Landscape With Key Players:
The competitive landscape of the dry age macular degeneration market has been studied in the report with the detailed profiles of the key players operating in the market.
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=7978&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com/
